HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N1- (6- quinolyl)- 2- oxo- 2- (1- (3- thienylmethyl)- 1H- 3- indolyl)acetamide

structure in first source

Also Known As:

BPR0C305

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - N1-(6-quinolyl)-2-oxo-2-(1-(3-thienylmethyl)-1H-3-indolyl)acetamide: 1
    - Quinolines: 146
      - Aminoquinolines: 29
        N1-(6-quinolyl)-2-oxo-2-(1-(3-thienylmethyl)-1H-3-indolyl)acetamide: 1

Experts

1.	Chao, Yu-Sheng: 1 article (11/2013)
2.	Chen, Ching-Ping: 1 article (11/2013)
3.	Chen, Chiung-Tong: 1 article (11/2013)
4.	Chen, Tung-Wei: 1 article (11/2013)
5.	Hsieh, Chih-Chien: 1 article (11/2013)
6.	Li, Wen-Tai: 1 article (11/2013)
7.	Lin, Chi-Hung: 1 article (11/2013)
8.	Lin, Heng-Liang: 1 article (11/2013)
9.	Shen, Chien-Chang: 1 article (11/2013)
10.	Song, Jen-Shin: 1 article (11/2013)

Related Diseases

1.

Neoplasms (Cancer)

11/01/2013 - "BPR0C305 is a novel N-substituted indolyl glyoxylamide previously reported with in-vitro cytotoxic activity against a panel of human cancer cells including P-gp-expressing multiple drug-resistant cell sublines. "
11/01/2013 - "BPR0C305 is a novel synthetic small indole derivative that demonstrates in-vitro activities against human cancer cell growth by inhibiting tubulin polymerization, disrupting cellular microtubule assembly, and causing cell cycle arrest at the G2/M phase. "

Related Drugs and Biologics

1.	Tubulin
2.	indole